Queen's University at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Queen's University takes part in 4 sessions at ESMO 2026 in Madrid. Its program centres on cancer policy and the value of evidence, including critical reading of clinical trials and whether US and European regulators agree on drugs approved from phase 2 data. It also models the global economic cost of early lung cancer deaths and studies questions patients ask their oncologist.

OrganizationESMO 2026 Attendance
Queen's University
Kingston, Canada
queensu.ca
University & institute
Public research university in Kingston, Ontario, Canada, with a school of medicine and home to a national cancer trials group.
Talk
Fri Oct 23
13:30–13:50
How do I read and interpret a cancer clinical trial? Perspectives on critical appraisal from a practising clinician
Quantifying the magnitude of clinical benefit in a changing trial landscape
Abstract
Sat Oct 24
15:05–15:10
Abstract
Sun Oct 25
10:25–10:35
Abstract
Sun Oct 25
16:30–16:35
3469RO - Questions to Ask Your Oncologist: A Global Study by the Common Sense Oncology (CSO) Initiative
Rapid oral: Supportive and palliative care
Nursing & supportive care

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Queen's University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction